Savara Announces Chief Medical Officer (CMO) Transition

Core Viewpoint - Savara Inc. has announced the promotion of Dr. Yasmine Wasfi to Chief Medical Officer (CMO), effective immediately, succeeding Dr. Ray Pratt who will become Senior Medical Advisor [1] Company Summary - Savara Inc. is a clinical stage biopharmaceutical company focused on rare respiratory diseases [1] - Dr. Wasfi will report directly to the Company's Chair and Chief Executive Officer and will be part of the executive leadership team [1]